Keywords: Sinclair IS Pharma, Flammacerium, Hikma, MENA region, Burn wounds, Fazol G, Labs Majorelle, Gynecology

Sinclair IS in Flammacerium deal with Hikma; sells Fazol G to Majorelle

Article | 19 March 2013

Print This

UK specialty pharma firm Sinclair IS Pharma (AIM: SPH.L) and Jordon-headquartered Hikma Pharmaceuticals (LSE:HIK) signed an exclusive 10-year ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in